Back
ProShares S&P Kensho Cleantech ETF Vs. Rhythm Pharmaceuticals, Inc. Sector Stock Comparison
Buy
65
CTEX
ProShares S&P Kensho Cleantech ETF
Last Price:
$38.75
Seasonality Move:
-6.55%
Buy
61
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$117.57
Seasonality Move:
-9.01%
Buy
65
ProShares S&P Kensho Cleantech ETF (CTEX)
is a Buy
Is ProShares S&P Kensho Cleantech ETF a Buy, Sell or Hold?
-
The current ProShares S&P Kensho Cleantech ETF [CTEX] share price is $38.93. The Score for CTEX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
CTEX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.77. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CTEX Stock Price Chart
What is ProShares S&P Kensho Cleantech ETF's stock price today?
-
The ProShares S&P Kensho Cleantech ETF share price today is $38.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CTEX is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight buying pressure.
CTEX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 63.77 | Buy |
| Chaikin Money Flow: | 5128 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 51.18 | Buy |
| Chaikin Money Flow: | 492572 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CTEX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.91 | Buy |
| 20-day SMA: | 35.18 | Buy |
| 50-day SMA: | 35.78 | Buy |
| 200-day SMA: | 25.3 | Buy |
| 8-day EMA: | 37.12 | Buy |
| 20-day EMA: | 36.18 | Buy |
| 50-day EMA: | 34.26 | Buy |
| 200-day EMA: | 20.06 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 104 | Buy |
| 20-day SMA: | 103.19 | Buy |
| 50-day SMA: | 104.46 | Buy |
| 200-day SMA: | 81.11 | Buy |
| 8-day EMA: | 104.12 | Buy |
| 20-day EMA: | 104.09 | Buy |
| 50-day EMA: | 102.96 | Buy |
| 200-day EMA: | 86.07 | Buy |
ProShares S&P Kensho Cleantech ETF Earnings Growth & CTEX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.
ProShares S&P Kensho Cleantech ETF Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||